Intermittent Fasting for NAFLD in Adults

Part of paid clinical trials in Boston, Massachusetts.

Sponsor
Massachusetts General Hospital
Study ID
NCT04899102
Status
Recruiting
Apply to this trial

Conditions

  • Fatty Liver
  • Fatty Liver, Nonalcoholic
  • Intermittent Fasting
  • Liver Fat
  • Non-Alcoholic Fatty Liver Disease

Eligibility Criteria

Sex
ALL
Age
18 Years - N/A
Healthy Volunteers
Not accepted

Interventions

  • Time-Restricted, Intermittent Fasting — BEHAVIORAL
    A special type of diet for 6 weeks, called time-restricted, intermittent fasting.

Study Details

NAFLD is a growing threat to public health. Currently, there is a significant need for highly effective treatments for NAFLD. Non-obese NAFLD (BMI\<30kg/m2) is an increasingly recognized condition, sometimes described as "lean NAFLD". Intermittent Fasting (IF) may be uniquely beneficial in non-obese NAFLD. The purpose of this study is to identify non-pharmacologic, lifestyle-based methods of NAFLD treatment within non-obese adults.

Key Dates

Start date
Feb 1, 2022
Status verified
Oct 2025
Primary completion
Jul 31, 2026
Completion
Jul 31, 2026

Study Design

Enrollment
25 participants (estimated)
Allocation
NA
Intervention model
SINGLE_GROUP
Primary purpose
TREATMENT

Arms

  • Experimental: Time-Restricted, Intermittent Fasting Group
    Special type of diet for 6 weeks, called time-restricted, intermittent fasting.

Primary Outcome Measure

Liver Fat Content [ Time Frame: change from baseline to 6 weeks ]

Central Contacts

Locations (1)

FacilityCityStateZIPSite coordinators
Massachusetts General HospitalBostonMassachusetts02114
Kathleen E Corey, MD/MPH
[email protected]
6177265925
Megan Michta, BA
[email protected]
6176439458

Find similar trials in Boston, MA

By research site
Massachusetts General Hospital· Boston, MA

Related Studies